Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) price on Thursday, July 11, rose 0.34% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $17.04.
A look at the stock’s price movement, the level at last check in today’s session was $16.98. Turning to its 52-week performance, $17.69 and $7.92 were the 52-week high and 52-week low respectively. Overall, TEVA moved 1.12% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Teva- Pharmaceutical Industries Ltd. ADR’s market cap currently stands at around $19.30 billion.
Analysts have a consensus estimate of 4.04B for the company’s revenue for the quarter, with a low and high estimate of 4.01B and 4.07B respectively. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 16.02B, representing a 1.10% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TEVA is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
TEVA’s current price about 1.94% and 4.50% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.28, while 7-day volatility ratio is 3.47% and 2.95% in the 30-day chart. Further, Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has a beta value of 0.90, and an average true range (ATR) of 0.51.
If we refocus on Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA), historical trading data shows that trading volumes averaged 10.11 million over the past 3 months. The company’s latest data on shares outstanding shows there are 1.13 billion shares.
The 0.01% of Teva- Pharmaceutical Industries Ltd. ADR’s shares are in the hands of company insiders while institutional holders own 52.74% of the company’s shares. Current price change has pushed the stock 63.20% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TEVA stock continues to rise going into the next quarter.
